期刊文献+

mdr-1、CD44v、和nm23-H1基因产物与肝癌侵袭及转移的关系 被引量:2

Thesignificance and expression of mdr 1、CD44v and nm23 H1 in liver carcinoma
下载PDF
导出
摘要 为探讨mdr- 1 、CD44v 和nm23 - H1 基因产物蛋白与肝癌侵袭、转移预后的关系。用免疫组织化学技术检测46 例肝癌患者CD44v 和nm23 - H1 和mdr- 1 基因蛋白的表达。结果显示肝癌组织mdr- 1 、CD44v 和nm23 - H1(60-08 % ) ,明显高于正常组织和癌旁组织( P< 0-05) ;肝癌转移组的mdr- 1 、CD44v 阳性表达率高于nm23 - H1 阳性表达率,差异显著( P< 0-05) ;肝癌非转移组的nm23 - H1 阳性表达率显著高于mdr- 1 、CD44v 阳性表达率( P< 0-05) 。肝癌转移组mdr- 1 、CD44v 明显高于非转移组,而nm23 - H1 则反之( P< 0-05) 。肝癌的侵袭、转移及预后可能与mdr- 1 、CD44v 和nm23 - H1 三种基因产物的异常表达有关。 To probe the relationship betwwen the gene products of mdr 1,CD44v,nm23 H1 and inva sion,prognosis and metastasisin liver carcinoma-The expression of mdr 1 ,CD44v and nm23 H1 in 46 cases of liver carcinoma were studied by im munohistochemitry-Results:mdr 1 ,CD44v and nm23 H1 were expressed at a higherlevelinlivercarcinoma than that mormaland pericarcinomatoustissues( P< 0-05) ,and Theexpression of mdr 1 and CD44v werestrongerthan thatofnm23 H1 in metastasis( P< 0-05)-The expression of nm23 H1(73-33 % )were markly stronger than those of mdr 1 and CD44v in no metastasis( P< 0-05)-The three gene productsin metastasis were markly differentthan thosein no metastasis( P< 0-05)-Conclution :Theabnormalexpression of mdr 1 ,CD44v and nm23 H1 wererelated toinvasion ,metastasis and prognosis ofliver cancer-
出处 《临床肝胆病杂志》 CAS 北大核心 1999年第2期88-90,共3页 Journal of Clinical Hepatology
关键词 肝肿瘤 基因表达 免疫组化 livercarcinoma gene expression im munohistochemistry
  • 相关文献

参考文献1

二级参考文献5

  • 1丛文铭,Cancer,1993年,71卷,2941页
  • 2Tsui W M S,J Clin Pathol,1992年,45卷,975页
  • 3丛文铭,Cancer,1990年,66卷,498页
  • 4应越英,原发性肝癌的研究与进展,1990年,65页
  • 5朱世能,中华病理学杂志,1982年,11卷,198页

共引文献61

同被引文献28

  • 1方伟岗.肿瘤细胞侵袭转移的分子生物学基础[J].中华医学杂志,1994,74(7):447-450. 被引量:10
  • 2刘鹏飞,吴孟超,陈汉,钱光相,傅继梁.原发性肝癌CD44v mRNA表达与肝癌复发的关系[J].第二军医大学学报,1996,17(6):561-563. 被引量:5
  • 3刘鹏飞,吴孟超,陈汉,钱光相,傅继梁.CD_(44)剪接变异体在早期肝癌的表达及其临床意义[J].肿瘤,1996,16(5):532-534. 被引量:7
  • 4Ham HI, Ho LI, Shyu RY, et al. Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma[J]. J Clin Gostroenterol, 1996,22(2):107- 110.
  • 5Washington K ,Telen MJ, Gottfried MR. Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study[J].Liver,1997,17(1):17-23.
  • 6Gunthert U, Hofmann M, Qudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells[J]. Cell, 1991,65(1):13-24.
  • 7Haynes BF,Telen M J, Hale LP,et al. CD44-a molecule involved in leukocyte adherence and T-cell activation[J]. Immunol Today, 1989,10(12):423-428.
  • 8Arch R, Wirth K, Hofmann M, et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44[J]. Science, 1992,257: 682-685.
  • 9Hofmann M, Rudy W, Gunrhert U, et al. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells[J]. Cancer Res, 1993,53(7): 1 516 - 1 521.
  • 10Underhill C. CD44 : the hyaluronan receptor [J]. J Cell Sci, 1992, 103(Pt2):293-298.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部